Physician profile
Carol Raymond
NPI 1699719070
$2,820.59
in general payments reported to CMS, 2019-2025
23 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $292 · 2022: $317 · 2023: $1,024 · 2024: $656 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,211.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $672.77 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $322.82 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $221.29 | 2021-2023 | Verquvo |
| Abbott Laboratories | $217.78 | 2021-2025 | Aveir, Merlin@Home, Assurity |
| Irhythm Technologies, INC. | $204.09 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Esperion Therapeutics, INC. | $200.15 | 2021-2025 | Nexletol |
| Amgen INC. | $126.66 | 2023-2025 | Repatha, Repatha |
| Novo Nordisk INC | $117.35 | 2022-2024 | Ozempic, Rybelsus |
| Baxter Healthcare | $107.19 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.58 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $88.50 | 2023-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $82.84 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $63.95 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $47.86 | 2021-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.08 | 2022-2024 | Lifevest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $37.63 | 2023-2024 | |
| Lilly USA, LLC | $36.56 | 2023 | Mounjaro |
| Kestra Medical Technology Services, INC. | $29.63 | 2025 | Assure Wcd |
| Daiichi Sankyo INC. | $26.58 | 2024 | Injectafer |
| Philips North America LLC | $22.48 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Inspire Medical Systems, INC. | $17.09 | 2025 | Inspire |
| Boston Scientific Corporation | $15.78 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Raymond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.